Article Listing - Abbott presents new Humira data at ACR

PHARMA ECONOMICS 1942/1992 PERSPECTIVE

23 March 1992

Enoch Powell, who was Minister of Health in the UK back in the 60s, and responsible for what would now...

FROM A RESEARCH-LED TO A MARKET-DRIVEN FIRM

23 March 1992

The task ofpharmaceutical industry management is to achieve the best possible balance between the constant pull of the market...

MORE EXPANSION AT CHILE'S LABS SAVAL

23 March 1992

Laboratorios Saval of Santiago in Chile, which is the third largest drugmaker in the ranking compiled by the national and...

FORTHCOMING MEETINGS

23 March 1992

The following Rostrum-organized meetings of potential interest to pharmaceutical industry personnel will be held at The Royal Society of Medicine,...

UK REGULATIONS ON HIV TESTING

23 March 1992

New regulations by the UK government aimed at controlling the sale and use of HIV testing kits will come into...

COMPARATIVE STUDY CALL WITH ZOFRAN

23 March 1992

Glaxo's 5-HT3 receptor antagonist anti-emetic Zofran (ondansetron) represents a great improvement on earlier anti-emetics for chemotherapy regimens that include cisplatin,...

STRONGER WARNINGS ON ACE INHIBITORS

23 March 1992

At the request of the US Food and Drug Administration, six manufacturers of ACE inhibitors are putting stronger warning labels...

SOMATOGEN'S rhB1.1 BLOOD SUBSTITUTE

23 March 1992

A collaborative research project between Somatogen and the UK Medical Research Council's Laboratory of Molecular Biology, Cambridge, has published a...

STOCK MARKET COMMENTARY: EUROPE

23 March 1992

EUROPE: stock markets were nearly all down, with the lead coming from New York and Tokyo. On the FRANKFURT exchange,...

DANISH COMPLAIN OVER GLAXO PRICING

23 March 1992

Oral use of Pfizer's triazole antifungal Diflucan (fluconazole) has been deemed superior to weekly intravenous injections of amphotericin B to...

Showing 94611-94620 of 95376 articles